Global Drugs for Anti-Infective Market Research Report 2019

Table of Contents

Executive Summary

1 Drugs for Anti-Infective Market Overview

• 1.1 Product Overview and Scope of Drugs for Anti-Infective
• 1.2 Drugs for Anti-Infective Segment by Type
  • 1.2.1 Global Drugs for Anti-Infective Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 OTC
  • 1.2.3 Rx Drugs
• 1.3 Drugs for Anti-Infective Segment by Application
  • 1.3.1 Drugs for Anti-Infective Consumption Comparison by Application (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Drugs Store
  • 1.3.4 Other
• 1.4 Global Drugs for Anti-Infective Market by Region
  • 1.4.1 Global Drugs for Anti-Infective Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Drugs for Anti-Infective Market Size
  • 1.5.1 Global Drugs for Anti-Infective Revenue (2014-2025)
  • 1.5.2 Global Drugs for Anti-Infective Production (2014-2025)

2 Global Drugs for Anti-Infective Market Competition by Manufacturers

• 2.1 Global Drugs for Anti-Infective Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Drugs for Anti-Infective Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Drugs for Anti-Infective Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Drugs for Anti-Infective Production Sites, Area Served, Product Types
• 2.5 Drugs for Anti-Infective Market Competitive Situation and Trends
  • 2.5.1 Drugs for Anti-Infective Market Concentration Rate
  • 2.5.2 Drugs for Anti-Infective Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Drugs for Anti-Infective Production Market Share by Regions

• 3.1 Global Drugs for Anti-Infective Production Market Share by Regions
• 3.2 Global Drugs for Anti-Infective Revenue Market Share by Regions (2014-2019)
• 3.3 Global Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Drugs for Anti-Infective Production
  • 3.4.1 North America Drugs for Anti-Infective Production Growth Rate (2014-2019)
  • 3.4.2 North America Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Drugs for Anti-Infective Production
  • 3.5.1 Europe Drugs for Anti-Infective Production Growth Rate (2014-2019)
  • 3.5.2 Europe Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Drugs for Anti-Infective Production (2014-2019)
  • 3.6.1 China Drugs for Anti-Infective Production Growth Rate (2014-2019)
  • 3.6.2 China Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Drugs for Anti-Infective Production (2014-2019)
  • 3.7.1 Japan Drugs for Anti-Infective Production Growth Rate (2014-2019)
  • 3.7.2 Japan Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Drugs for Anti-Infective Consumption by Regions

• 4.1 Global Drugs for Anti-Infective Consumption by Regions
• 4.2 North America Drugs for Anti-Infective Consumption (2014-2019)
• 4.3 Europe Drugs for Anti-Infective Consumption (2014-2019)
• 4.4 China Drugs for Anti-Infective Consumption (2014-2019)
• 4.5 Japan Drugs for Anti-Infective Consumption (2014-2019)

5 Global Drugs for Anti-Infective Production, Revenue, Price Trend by Type

• 5.1 Global Drugs for Anti-Infective Production Market Share by Type (2014-2019)
• 5.2 Global Drugs for Anti-Infective Revenue Market Share by Type (2014-2019)
• 5.3 Global Drugs for Anti-Infective Price by Type (2014-2019)
• 5.4 Global Drugs for Anti-Infective Production Growth by Type (2014-2019)

6 Global Drugs for Anti-Infective Market Analysis by Applications

• 6.1 Global Drugs for Anti-Infective Consumption Market Share by Application (2014-2019)
• 6.2 Global Drugs for Anti-Infective Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Drugs for Anti-Infective Business

• 7.1 GlaxoSmithKline
  • 7.1.1 GlaxoSmithKline Drugs for Anti-Infective Production Sites and Area Served
  • 7.1.2 Drugs for Anti-Infective Product Introduction, Application and Specification
  • 7.1.3 GlaxoSmithKline Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Merck
  • 7.2.1 Merck Drugs for Anti-Infective Production Sites and Area Served
  • 7.2.2 Drugs for Anti-Infective Product Introduction, Application and Specification
  • 7.2.3 Merck Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Pfizer
  • 7.3.1 Pfizer Drugs for Anti-Infective Production Sites and Area Served
  • 7.3.2 Drugs for Anti-Infective Product Introduction, Application and Specification
  • 7.3.3 Pfizer Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Novartis AG
  • 7.4.1 Novartis AG Drugs for Anti-Infective Production Sites and Area Served
  • 7.4.2 Drugs for Anti-Infective Product Introduction, Application and Specification
  • 7.4.3 Novartis AG Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Gilead Sciences
  • 7.5.1 Gilead Sciences Drugs for Anti-Infective Production Sites and Area Served
  • 7.5.2 Drugs for Anti-Infective Product Introduction, Application and Specification
  • 7.5.3 Gilead Sciences Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Abbott
  • 7.6.1 Abbott Drugs for Anti-Infective Production Sites and Area Served
  • 7.6.2 Drugs for Anti-Infective Product Introduction, Application and Specification
  • 7.6.3 Abbott Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Wyeth
  • 7.7.1 Wyeth Drugs for Anti-Infective Production Sites and Area Served
  • 7.7.2 Drugs for Anti-Infective Product Introduction, Application and Specification
  • 7.7.3 Wyeth Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Sanofi-Aventis
  • 7.8.1 Sanofi-Aventis Drugs for Anti-Infective Production Sites and Area Served
  • 7.8.2 Drugs for Anti-Infective Product Introduction, Application and Specification
  • 7.8.3 Sanofi-Aventis Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Bristol-Myers Squibb
  • 7.9.1 Bristol-Myers Squibb Drugs for Anti-Infective Production Sites and Area Served
  • 7.9.2 Drugs for Anti-Infective Product Introduction, Application and Specification
  • 7.9.3 Bristol-Myers Squibb Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Johnson
  • 7.10.1 Johnson Drugs for Anti-Infective Production Sites and Area Served
  • 7.10.2 Drugs for Anti-Infective Product Introduction, Application and Specification
  • 7.10.3 Johnson Drugs for Anti-Infective Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Roche Pharma AG
• 7.12 Nanosphere
• 7.13 NanoViricides
• 7.14 Novabay Pharmaceuticals
• 7.15 Obetech
• 7.16 Optimer Pharmaceuticals
• 7.17 Basilea Pharmaceutica AG
• 7.18 Daiichi Sankyo
• 7.19 MerLion Pharma
• 7.20 Theravance

8 Drugs for Anti-Infective Manufacturing Cost Analysis

• 8.1 Drugs for Anti-Infective Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Drugs for Anti-Infective
• 8.4 Drugs for Anti-Infective Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Drugs for Anti-Infective Distributors List
• 9.3 Drugs for Anti-Infective Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Drugs for Anti-Infective Market Forecast

• 11.1 Global Drugs for Anti-Infective Production, Revenue Forecast
  • 11.1.1 Global Drugs for Anti-Infective Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Drugs for Anti-Infective Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Drugs for Anti-Infective Price and Trend Forecast (2019-2025)
• 11.2 Global Drugs for Anti-Infective Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Drugs for Anti-Infective Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Drugs for Anti-Infective Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Drugs for Anti-Infective Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Drugs for Anti-Infective Production, Revenue Forecast (2019-2025)
• 11.3 Global Drugs for Anti-Infective Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Drugs for Anti-Infective Consumption Forecast (2019-2025)
  • 11.3.2 Europe Drugs for Anti-Infective Consumption Forecast (2019-2025)
  • 11.3.3 China Drugs for Anti-Infective Consumption Forecast (2019-2025)
  • 11.3.4 Japan Drugs for Anti-Infective Consumption Forecast (2019-2025)
• 11.4 Global Drugs for Anti-Infective Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Drugs for Anti-Infective Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List